Your search history is turned on.
Date: April 30, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd in an Induced State of Alcohol Intoxication TORONTO, ON April 30, 2024 FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (FSD Pharma of the Company), a biopharmaceutic...
Date: April 25, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Provides Update from Celly Nus Partnership with Six+One for unbuzzd Toronto, ON April 25, 2024 FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (FSD Pharma), provides an update by way of a news release issued by Celly Nutrition Corp. (Celly Nu), and its launching of unbuzzd, an innovative beverage product that is scientifical...
Date: April 22, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way of a news release issued by Celly Nutrition Corp. ("Celly Nu"), and its launching of unbuzzd, an innovative beverage product that is scien...
Date: April 17, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products TORONTO, ON April 17, 2024 FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (FSD Pharma or the Company), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to ad...
Date: April 15, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Provides Update on its Investment in Celly Nutrition Corp., a Company Launching a Product that can assist in Expediting Alcohol Metabolism and Faster Recovery from Alcohol Consumption Toronto, ON April 15, 2024 FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (FSD Pharma), provides an update on its investment in Celly Nutrition ...
Date: April 8, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
157127106.2 FSD Pharma Inc. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency TORONTO--(BUSINESS WIRE)APRIL 7, 2024--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRE: 0K9A) (FSD Pharma or the Company), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affectin...
Date: April 1, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Saskatchewan, Yukon
FSD Pharma Announces Filing of Year-End 2023 Results TORONTO, ON / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announced that the Comp...
EDGAR SUBMISSION SUMMARY Issuer Name FSD Pharma Inc. Submission Type 20-F Live File On Return Copy On Exchange NASD Confirming Copy Off Filer CIK 0001771885 Filer CCC xxxxxxxx Period of Report 12-31-2023 Shell Company Off Emerging Growth Company Yes Elected not to use the extended transition period for complying with any new or revised financial accounting standards No Not...
Date: March 28, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, COYLE, Nathan, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...